LESLIE WIGHTON MCQUIRE,MICHAEL SHULTZ,OLIVIER ROGEL,RIBEN ALBERTO TOMMASI,SVEN WEILER
申请号：
BRPI0915762
公开号：
BRPI0915762A2
申请日:
2009.07.13
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
The present invention provides a compound of formula (I) said compound is inhibitor of MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-12 and/or MMP-13. Finally, the present invention also provides pharmaceutical composition that include the compound of formula (I).
